These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19738023)

  • 41. In vitro activity of tigecycline against Acinetobacter baumannii isolates from a teaching hospital in Malaysia.
    Dhabaan GN; AbuBakar S; Shorman MA; Hassan H
    J Chemother; 2012 Apr; 24(2):87-92. PubMed ID: 22546763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colistin and Tigecycline Resistance in Carbapenem-Resistant Enterobacteriaceae: Checkmate to Our Last Line Of Defense.
    Kumar M
    Infect Control Hosp Epidemiol; 2016 May; 37(5):624-5. PubMed ID: 27077365
    [No Abstract]   [Full Text] [Related]  

  • 43. Decreased susceptibility to tigecycline in Acinetobacter baumannii mediated by a mutation in trm encoding SAM-dependent methyltransferase.
    Chen Q; Li X; Zhou H; Jiang Y; Chen Y; Hua X; Yu Y
    J Antimicrob Chemother; 2014 Jan; 69(1):72-6. PubMed ID: 23928024
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clonality, outer-membrane proteins profile and efflux pump in KPC- producing Enterobacter sp. in Brazil.
    Rosa JF; Rizek C; Marchi AP; Guimaraes T; Miranda L; Carrilho C; Levin AS; Costa SF
    BMC Microbiol; 2017 Mar; 17(1):69. PubMed ID: 28302074
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of view.
    Curcio D; Fernández F; Jones RN; Ferraro MJ; Reller LB; Schreckenberger PC; Sader HS
    J Clin Microbiol; 2007 Jun; 45(6):2095; author reply 2095-6. PubMed ID: 17548459
    [No Abstract]   [Full Text] [Related]  

  • 46. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae: mechanisms of macrolide and tetracycline resistance.
    Betriu C; Culebras E; Rodríguez-Avial I; Gómez M; Sánchez BA; Picazo JJ
    Antimicrob Agents Chemother; 2004 Jan; 48(1):323-5. PubMed ID: 14693558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic characterisation of clinical Klebsiella pneumoniae isolates with reduced susceptibility to tigecycline: Role of the global regulator RamA and its local repressor RamR.
    Wang X; Chen H; Zhang Y; Wang Q; Zhao C; Li H; He W; Zhang F; Wang Z; Li S; Wang H
    Int J Antimicrob Agents; 2015 Jun; 45(6):635-40. PubMed ID: 25681067
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro activities of tigecycline against the Bacteroides fragilis group.
    Jacobus NV; McDermott LA; Ruthazer R; Snydman DR
    Antimicrob Agents Chemother; 2004 Mar; 48(3):1034-6. PubMed ID: 14982803
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin.
    Endimiani A; Patel G; Hujer KM; Swaminathan M; Perez F; Rice LB; Jacobs MR; Bonomo RA
    Antimicrob Agents Chemother; 2010 Jan; 54(1):526-9. PubMed ID: 19901089
    [TBL] [Abstract][Full Text] [Related]  

  • 51.
    Gravey F; Cattoir V; Ethuin F; Fabre L; Beyrouthy R; Bonnet R; Le Hello S; Guérin F
    Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32778545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.
    Dean CR; Visalli MA; Projan SJ; Sum PE; Bradford PA
    Antimicrob Agents Chemother; 2003 Mar; 47(3):972-8. PubMed ID: 12604529
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mutant prevention concentration of tigecycline for Klebsiella pneumoniae isolates with four different resistance statuses.
    Zhong X; Xu HT; Chen DK; Hu X; Cheng G
    J Infect Dev Ctries; 2015 Oct; 9(10):1177-9. PubMed ID: 26517496
    [No Abstract]   [Full Text] [Related]  

  • 54. Tigecycline minimum inhibitory concentration for carbapenem-resistant Acinetobacter baumannii by two methods.
    Wang R; Wang H; She D
    Chin Med J (Engl); 2014; 127(10):1997. PubMed ID: 24824274
    [No Abstract]   [Full Text] [Related]  

  • 55. In vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii and Stenotrophomonas maltophilia.
    Insa R; Cercenado E; Goyanes MJ; Morente A; Bouza E
    J Antimicrob Chemother; 2007 Mar; 59(3):583-5. PubMed ID: 17213264
    [No Abstract]   [Full Text] [Related]  

  • 56. In vitro activities of tigecycline (GAR-936) and 12 other antimicrobial agents against 90 Eikenella corrodens clinical isolates.
    Cercenado E; Cercenado S; Bouza E
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2644-5. PubMed ID: 12878532
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
    Vega S; Dowzicky MJ
    Ann Clin Microbiol Antimicrob; 2017 Jul; 16(1):50. PubMed ID: 28701170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AdeABC-mediated efflux and tigecycline MICs for epidemic clones of Acinetobacter baumannii.
    Hornsey M; Ellington MJ; Doumith M; Thomas CP; Gordon NC; Wareham DW; Quinn J; Lolans K; Livermore DM; Woodford N
    J Antimicrob Chemother; 2010 Aug; 65(8):1589-93. PubMed ID: 20554571
    [TBL] [Abstract][Full Text] [Related]  

  • 59. EUCAST technical note on tigecycline.
    European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee
    Clin Microbiol Infect; 2006 Nov; 12(11):1147-9. PubMed ID: 17063597
    [No Abstract]   [Full Text] [Related]  

  • 60. Influence of media and testing methodology on susceptibility to tigecycline of Enterobacteriaceae with reported high tigecycline MIC.
    Torrico M; González N; Giménez MJ; Alou L; Sevillano D; Navarro D; Díaz-Antolín MP; Larrosa N; Aguilar L; Garcia-Escribano N
    J Clin Microbiol; 2010 Jun; 48(6):2243-6. PubMed ID: 20351208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.